Sonnet Biotherapeutics
Price & Volume
Stats
See moreOpen | $4.80 |
Previous Close | $4.89 |
Day Range | $4.25-$4.80 |
52W Range | $1.08-$10.38 |
Market Cap | $36.3M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $1M |
Revenue Growth (YoY) | 5,268.8% |
Gross Profit (12 Mos) | -$767,527 |
Diluted EPS | -$6.82 |
News
See moreYahoo Finance • 11 days ago
Sonnet to Present at the MedInvest Biotech & Pharma Conference
Yahoo Finance • 2 months ago
Sonnet Releases Virtual Investor "What This Means" Segment
Yahoo Finance • 2 months ago
This Cancer Biotech Company Is Making a Big Bet on the HYPE Crypto. Should You Buy Its Stock Here?
Yahoo Finance • 2 months ago
Sonnet BioTherapeutics Expands Clinical Evaluation of SON-1010 Dose Escalation with Atezolizumab in Ovarian Cancer
About
CEO | Mr. Raghu Rao |
CFO | Mr. Donald J. Griffith CPA, CPA |
Address | 100 Overlook Center, Princeton, NJ, United States, 08540 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 13 |
